|
Q2 FY2026
As of Jun 29, 2026
|
Q1 FY2026
As of Mar 30, 2026
|
Q4 FY2025
As of Dec 29, 2025
|
Q3 FY2025
As of Sep 29, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 30, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jul 1, 2024
|
Q1 FY2024
As of Apr 1, 2024
|
Q4 FY2023
As of Jan 1, 2024
|
Q3 FY2023
As of Oct 2, 2023
|
Q2 FY2023
As of Jul 3, 2023
|
Q1 FY2023
As of Apr 3, 2023
|
Q4 FY2022
As of Jan 2, 2023
|
Q3 FY2022
As of Oct 3, 2022
|
Q2 FY2022
As of Jul 4, 2022
|
Q1 FY2022
As of Apr 4, 2022
|
Q4 FY2021
As of Jan 3, 2022
|
Q3 FY2021
As of Sep 27, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Receivable from sale of Shanghai E-MS (SH E-MS) property | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Definite-lived intangibles, net | ||||||||||||||||||||
| Deposits and other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term debt, including current portion of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Accrued salaries, wages, and benefits | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of discount and issuance costs | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock, $ 0.001 par value; 300,000 shares authorized, 115,197 shares issued as of June 29, 2026 and December 29, 2025; 105,343 and 103,379 shares outstanding as of June 29, 2026 and December 29, 2025, respectively | ||||||||||||||||||||
| Treasury stock - common stock at cost; 9854 and 11,818 shares as of June 29, 2026 and December 29, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
